Chris Conn

Company: Amgen

Job title: Director, Clinical Biomarkers & Diagnostics, Global Diagnostics Strategy Lead

Seminars:

Panel Discussion: Balancing Innovation & Compliance in Diagnostic Testing Amidst the Final LDT Rule to Ensure Patient Access to Great Drugs 9:30 am

Debating the positive and negative aspects of the Final LDT Rule for liquid biopsy innovation Understanding the responsibilities for drug-diagnostic partnerships in ensuring swift approvals How can we minimize financial and temporal burdens of complex approvals in the US?Read more

day: Day Two AM

Panel Discussion: Harnessing MRD & ctDNA to Inform Clinical Trial Decision Making & Improve Dosage Regimens 3:30 pm

How to integrate MRD into clinical trial designs to tailor dosage regimes more precisely Leveraging MRD insights to refine dosage escalation and de-escalation protocols for optimal efficacy and safety How to use MRD data to adjust treatment strategies and inform Standard of Care protocolsRead more

day: Day One Track B (1)

Panel Discussion: Pre-Analytical Insights to Enhance Liquid Biopsy Development Success 5:30 pm

Ensure compliance with evolving global standards to future-proof your studies Optimize pre-analytical protocols to generate consistent, high-quality results that drive impactful discoveries Ensure your assays capture the right analytes with precision, leading to better clinical outcomesRead more

day: Day One Track A (2)